Utility of immunochemistry in cytology.

PubWeight™: 0.75‹?›

🔗 View Article (PMID 27279681)

Published in J Cytol on June 09, 2016

Authors

Pooja Chavali1, Aruna Kumari Prayaga1, Ashwani Tandon1, Shantveer Gurulingappa Uppin1

Author Affiliations

1: Department of Pathology, Nizam's Institute of Medical Sciences, Hyderabad, Telangana, India.

Articles cited by this

International association for the study of lung cancer/american thoracic society/european respiratory society international multidisciplinary classification of lung adenocarcinoma. J Thorac Oncol (2011) 21.49

Suitability of endobronchial ultrasound-guided transbronchial needle aspiration specimens for subtyping and genotyping of non-small cell lung cancer: a multicenter study of 774 patients. Am J Respir Crit Care Med (2012) 5.21

Immunocytochemistry in effusion cytology: a contemporary review. Cancer (2001) 1.25

Comparison of three commonly used cytologic preparations in effusion immunocytochemistry. Diagn Cytopathol (2002) 1.15

Estrogen and progesterone hormone receptor status in breast carcinoma: comparison of immunocytochemistry and immunohistochemistry. Indian J Cancer (2010) 1.15

Application of immunohistochemistry to cytology. Arch Pathol Lab Med (2008) 1.09

Clinicopathologic analysis of fine needle aspiration cytology of the thyroid. A review of 1,613 cases and correlation with histopathologic diagnoses. Acta Cytol (2003) 1.08

Subtyping of non-small cell lung carcinoma: a comparison of small biopsy and cytology specimens. J Thorac Oncol (2011) 1.07

Role of cytology in the management of non-small-cell lung cancer. J Clin Oncol (2011) 1.07

Accuracy of cell typing in nonsmall cell lung cancer by EBUS/EUS-FNA cytological samples. Eur Respir J (2011) 1.02

Accuracy of fine needle aspiration cytology in the pathological typing of non-small cell lung cancer. J Thorac Oncol (2011) 1.02

Immunocytochemistry in liquid-based cervical cytology: analysis of clinical use following a cross-sectional study. Int J Cancer (2006) 0.97

Cytologic differential diagnosis among reactive mesothelial cells, malignant mesothelioma, and adenocarcinoma: utility of combined E-cadherin and calretinin immunostaining. Cancer (2000) 0.93

Differentiating reactive mesothelial cells from metastatic adenocarcinoma in serous effusions: the utility of immunocytochemical panel in the differential diagnosis. Diagn Cytopathol (2009) 0.91

Ki-67 immunocytochemistry in liquid based cervical cytology: useful as an adjunctive tool? J Clin Pathol (2003) 0.90

Comparison of immunocytochemical sensitivity between formalin-fixed and alcohol-fixed specimens reveals the diagnostic value of alcohol-fixed cytocentrifuged preparations in malignant effusion cytology. Am J Clin Pathol (2011) 0.89

Evaluation of the sensitivity and specificity of immunohistochemical markers in the differential diagnosis of effusion cytology. Oman Med J (2013) 0.86

Immunocytochemistry in diagnostic cytology. Recent Results Cancer Res (1993) 0.84

Immunocytochemistry: It's role in diagnosis of undifferentiated neoplasms by fine needle aspiration cytology. J Cytol (2013) 0.83

Overview of the clinical immunohistochemistry laboratory: regulations and troubleshooting guidelines. Methods Mol Biol (1999) 0.82

Establishing a protocol for immunocytochemical staining and chromogenic in situ hybridization of Giemsa and Diff-Quick prestained cytological smears. Cytojournal (2012) 0.81

The application and diagnostic utility of immunocytochemistry on direct smears in the diagnosis of pulmonary adenocarcinoma and squamous cell carcinoma. Diagn Cytopathol (2011) 0.80